TV News LIES

A joint report into the handling of the H1N1 outbreak has found that some scientists who advised governments to stockpile drugs, had previously been on the payroll of big drug companies.

The report, published in the British Medical Journal, found World Health Organisation (WHO) guidelines on the use of medicine to treat the virus were prepared by experts who had received consulting fees from the top two manufacturers of the drugs - Roche and GlaxoSmithKline.

Health freedom has just been handed a significant victory by the United States District Court for the District of Columbia, which ruled last week that the U.S. Food and Drug Administration (FDA) violated the First Amendment rights of a nutritional supplement company when it censored truthful, scientifically-backed claims about how selenium can help reduce the risk of cancer.

Cigarette-smoking Americans receive higher doses of the most potent carcinogens than do smokers in many foreign countries because of variations in the way tobacco is processed for cigarettes, researchers from the Centers for Disease Control and Prevention reported Monday.

American cigarettes are typically made from "American blend" tobacco, a specific blend that, because of growing and curing practices, contains higher levels of cancer-causing tobacco-specific nitrosamines. The most popular Canadian, Australian and British brands, in contrast, are made from "bright" tobacco, which is lighter in color and cured differently.

Municipalities all across America are currently dripping fluoride chemicals into their public water supply, dosing over a hundred million Americans with a chemical that they claim "prevents cavities."

What's interesting here is that this biological effect of "preventing cavities" is a medical claim, according to the FDA. And as such, making this claim instantly and automatically transforms fluoride into a "drug" under currently FDA regulations.

A simple blood test that can detect a cancer before a tumour has taken shape has been developed by British scientists. Due to be introduced in Britain by early next year, it is described as offering a “paradigm shift” in cancer diagnosis.

The test is the first to identify accurately the signals sent out by a person’s immune system as a cancer germinates. Research suggests that such signals can be detected up to five years before a tumour is spotted, priming doctors to intervene at the earliest moment when a solid cancer appears.

A vaccine designed to protect against breast cancer is expected to be tested on women within the next two years.

It has been tested on mice and results suggest that it could prevent tumours appearing and attack those that are already present. If tests on women show similar results, it could be offered to women around the age of 40, when the risk of developing the disease rises.